{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T20:25:31Z","timestamp":1774902331291,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"crossref"}]},{"name":"China Scholarship Council-Deutscher Akademischer Austauschdienst","award":["202106380162"],"award-info":[{"award-number":["202106380162"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["444776998"],"award-info":[{"award-number":["444776998"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["444776998"],"award-info":[{"award-number":["444776998"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Research Council  Horizon 2020","award":["694913"],"award-info":[{"award-number":["694913"]}]},{"name":"Else Kr\u00f6ner-Fresenius Stiftung","award":["2012_A103, 2015_A228, and 2019_A104"],"award-info":[{"award-number":["2012_A103, 2015_A228, and 2019_A104"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12022-025-09862-3","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T04:40:57Z","timestamp":1746592857000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ABCC3 Is a Differential Marker of CYP11B2-Negative Zona Glomerulosa Cells in Human Adrenal Cortex"],"prefix":"10.1007","volume":"36","author":[{"given":"Yingxian","family":"Pang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanas","family":"Mir-Bashiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuolun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kn\u00f6sel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy Ann","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"9862_CR1","doi-asserted-by":"publisher","unstructured":"Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F et al (2017) Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. J Am Coll Cardiol 69: 1811\u20131820. https:\/\/doi.org\/10.1016\/j.jacc.2017.01.052","DOI":"10.1016\/j.jacc.2017.01.052"},{"key":"9862_CR2","doi-asserted-by":"publisher","unstructured":"Reincke M, Bancos I, Mulatero P, Scholl UI, Stowasser M, Williams TA (2021) Diagnosis and treatment of primary aldosteronism.  Lancet Diabetes Endocrinol  9: 876\u2013892. https:\/\/doi.org\/10.1016\/s2213-8587(21)00210-2","DOI":"10.1016\/s2213-8587(21)00210-2"},{"key":"9862_CR3","doi-asserted-by":"publisher","unstructured":"Yang J, Burrello J, Goi J, Reincke M, Adolf C, Asbach E et al (2025) Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort.  Lancet Diabetes Endocrinol  13: 119\u2013133. https:\/\/doi.org\/10.1016\/s2213-8587(24)00308-5","DOI":"10.1016\/s2213-8587(24)00308-5"},{"key":"9862_CR4","doi-asserted-by":"publisher","unstructured":"Monticone S, D\u2019Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F et al (2018) Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis.  Lancet Diabetes Endocrinol  6: 41\u201350. https:\/\/doi.org\/10.1016\/s2213-8587(17)30319-4","DOI":"10.1016\/s2213-8587(17)30319-4"},{"key":"9862_CR5","doi-asserted-by":"publisher","unstructured":"Williams TA, Gomez-Sanchez CE, Rainey WE, Giordano TJ, Lam AK, Marker A et al (2021) International Histopathology Consensus for Unilateral Primary Aldosteronism. J Clin Endocrinol Metab 106: 42\u201354. https:\/\/doi.org\/10.1210\/clinem\/dgaa484","DOI":"10.1210\/clinem\/dgaa484"},{"key":"9862_CR6","doi-asserted-by":"publisher","unstructured":"Mete O, Erickson LA, Juhlin CC, de Krijger RR, Sasano H, Volante M et al (2022) Overview of the 2022 WHO Classification of Adrenal Cortical Tumors. Endocr Pathol 33: 155\u2013196. https:\/\/doi.org\/10.1007\/s12022-022-09710-8","DOI":"10.1007\/s12022-022-09710-8"},{"key":"9862_CR7","doi-asserted-by":"publisher","unstructured":"Choi M, Scholl UI, Yue P, Bj\u00f6rklund P, Zhao B, Nelson-Williams C et al (2011) K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331: 768\u2013772. https:\/\/doi.org\/10.1126\/science.1198785","DOI":"10.1126\/science.1198785"},{"key":"9862_CR8","doi-asserted-by":"publisher","unstructured":"Scholl UI, Goh G, St\u00f6lting G, de Oliveira RC, Choi M, Overton JD et al (2013) Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet 45: 1050\u20131054. https:\/\/doi.org\/10.1038\/ng.2695","DOI":"10.1038\/ng.2695"},{"key":"9862_CR9","doi-asserted-by":"publisher","unstructured":"Beuschlein F, Boulkroun S, Osswald A, Wieland T, Nielsen HN, Lichtenauer UD et al (2013) Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet 45: 440\u2013444, 444e441\u2013442. https:\/\/doi.org\/10.1038\/ng.2550","DOI":"10.1038\/ng.2550"},{"key":"9862_CR10","doi-asserted-by":"publisher","unstructured":"Azizan EA, Poulsen H, Tuluc P, Zhou J, Clausen MV, Lieb A et al (2013) Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet 45: 1055\u20131060. https:\/\/doi.org\/10.1038\/ng.2716","DOI":"10.1038\/ng.2716"},{"key":"9862_CR11","doi-asserted-by":"publisher","unstructured":"Scholl UI, St\u00f6lting G, Nelson-Williams C, Vichot AA, Choi M, Loring E et al (2015) Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism. Elife 4: e06315. https:\/\/doi.org\/10.7554\/eLife.06315","DOI":"10.7554\/eLife.06315"},{"key":"9862_CR12","doi-asserted-by":"publisher","unstructured":"Fernandes-Rosa FL, Daniil G, Orozco IJ, G\u00f6ppner C, El Zein R, Jain V et al (2018) A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism. Nat Genet 50: 355\u2013361. https:\/\/doi.org\/10.1038\/s41588-018-0053-8","DOI":"10.1038\/s41588-018-0053-8"},{"key":"9862_CR13","doi-asserted-by":"publisher","unstructured":"Rege J, Bandulik S, Nanba K, Kosmann C, Blinder AR, Plain A et al (2023) Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism. Nat Genet 55: 1623\u20131631. https:\/\/doi.org\/10.1038\/s41588-023-01498-5","DOI":"10.1038\/s41588-023-01498-5"},{"key":"9862_CR14","doi-asserted-by":"publisher","unstructured":"Yang Y, Gomez-Sanchez CE, Jaquin D, Aristizabal Prada ET, Meyer LS, Kn\u00f6sel T et al (2019) Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth. Hypertension 74: 809\u2013816. https:\/\/doi.org\/10.1161\/hypertensionaha.119.13476","DOI":"10.1161\/hypertensionaha.119.13476"},{"key":"9862_CR15","doi-asserted-by":"publisher","unstructured":"Romero DG, Yanes LL, de Rodriguez AF, Plonczynski MW, Welsh BL, Reckelhoff JF et al (2007) Disabled-2 is expressed in adrenal zona glomerulosa and is involved in aldosterone secretion. Endocrinology 148: 2644\u20132652. https:\/\/doi.org\/10.1210\/en.2006-1509","DOI":"10.1210\/en.2006-1509"},{"key":"9862_CR16","doi-asserted-by":"publisher","unstructured":"Boulkroun S, Samson-Couterie B, Dzib JF, Lefebvre H, Louiset E, Amar L et al (2010) Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism. Hypertension 56: 885\u2013892. https:\/\/doi.org\/10.1161\/hypertensionaha.110.158543","DOI":"10.1161\/hypertensionaha.110.158543"},{"key":"9862_CR17","doi-asserted-by":"publisher","unstructured":"Williams TA, Monticone S, Crudo V, Warth R, Veglio F, Mulatero P (2012) Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis. Hypertension 59: 833\u2013839. https:\/\/doi.org\/10.1161\/hypertensionaha.111.188532","DOI":"10.1161\/hypertensionaha.111.188532"},{"key":"9862_CR18","doi-asserted-by":"publisher","unstructured":"Felizola SJ, Katsu K, Ise K, Nakamura Y, Arai Y, Satoh F et al (2015) Pre-B Lymphocyte Protein 3 (VPREB3) Expression in the Adrenal Cortex: Precedent for non-Immunological Roles in Normal and Neoplastic Human Tissues. Endocr Pathol 26: 119\u2013128. https:\/\/doi.org\/10.1007\/s12022-015-9366-7","DOI":"10.1007\/s12022-015-9366-7"},{"key":"9862_CR19","doi-asserted-by":"publisher","unstructured":"Gong S, Sun N, Meyer LS, Tetti M, Koupourtidou C, Krebs S et al (2023) Primary Aldosteronism: Spatial Multiomics Mapping of Genotype-Dependent Heterogeneity and Tumor Expansion of Aldosterone-Producing Adenomas. Hypertension 80: 1555\u20131567. https:\/\/doi.org\/10.1161\/hypertensionaha.123.20921","DOI":"10.1161\/hypertensionaha.123.20921"},{"key":"9862_CR20","doi-asserted-by":"publisher","unstructured":"Iwahashi N, Umakoshi H, Seki T, Gomez-Sanchez CE, Mukai K, Suematsu M et al (2022) Characterization of Aldosterone-producing Cell Cluster (APCC) at Single-cell Resolution. J Clin Endocrinol Metab 107: 2439\u20132448. https:\/\/doi.org\/10.1210\/clinem\/dgac394","DOI":"10.1210\/clinem\/dgac394"},{"key":"9862_CR21","doi-asserted-by":"publisher","unstructured":"Murakami M, Hara K, Ikeda K, Horino M, Okazaki R, Niitsu Y et al (2024) Single-Nucleus Analysis Reveals Tumor Heterogeneity of Aldosterone-Producing Adenoma. Hypertension 81: 361\u2013371. https:\/\/doi.org\/10.1161\/hypertensionaha.123.21446","DOI":"10.1161\/hypertensionaha.123.21446"},{"key":"9862_CR22","doi-asserted-by":"publisher","unstructured":"Kullak-Ublick GA, Beuers U, Paumgartner G (2000) Hepatobiliary transport. J Hepatol 32: 3\u201318. https:\/\/doi.org\/10.1016\/s0168-8278(00)80411-0","DOI":"10.1016\/s0168-8278(00)80411-0"},{"key":"9862_CR23","doi-asserted-by":"publisher","unstructured":"Kobayashi M, Funayama R, Ohnuma S, Unno M, Nakayama K (2016) Wnt-\u03b2-catenin signaling regulates ABCC3 (MRP3) transporter expression in colorectal cancer. Cancer Sci 107: 1776\u20131784. https:\/\/doi.org\/10.1111\/cas.13097","DOI":"10.1111\/cas.13097"},{"key":"9862_CR24","doi-asserted-by":"publisher","unstructured":"Sato Y, Kobayashi M, Ohira M, Funayama R, Maekawa M, Karasawa H et al (2024) Downregulation of ABCC3 activates MAPK signaling through accumulation of deoxycholic acid in colorectal cancer cells. Cancer Sci 115: 1778\u20131790. https:\/\/doi.org\/10.1111\/cas.16132","DOI":"10.1111\/cas.16132"},{"key":"9862_CR25","doi-asserted-by":"publisher","unstructured":"Liu H, Yue L, Hong W, Zhou J (2024) SMARCA4 (BRG1) activates ABCC3 transcription to promote hepatocellular carcinogenesis. Life Sci 347: 122605. https:\/\/doi.org\/10.1016\/j.lfs.2024.122605","DOI":"10.1016\/j.lfs.2024.122605"},{"key":"9862_CR26","doi-asserted-by":"publisher","unstructured":"Adamska A, Ferro R, Lattanzio R, Capone E, Domenichini A, Damiani V et al (2019) ABCC3 is a novel target for the treatment of pancreatic cancer. Adv Biol Regul 73: 100634. https:\/\/doi.org\/10.1016\/j.jbior.2019.04.004","DOI":"10.1016\/j.jbior.2019.04.004"},{"key":"9862_CR27","doi-asserted-by":"publisher","unstructured":"Yu Z, Zhang C, Wang H, Xing J, Gong H, Yu E et al (2014) Multidrug resistance-associated protein 3 confers resistance to chemoradiotherapy for rectal cancer by regulating reactive oxygen species and caspase-3-dependent apoptotic pathway. Cancer Lett 353: 182\u2013193. https:\/\/doi.org\/10.1016\/j.canlet.2014.07.025","DOI":"10.1016\/j.canlet.2014.07.025"},{"key":"9862_CR28","doi-asserted-by":"publisher","unstructured":"Seborova K, Kloudova-Spalenkova A, Koucka K, Holy P, Ehrlichova M, Wang C et al (2021) The Role of TRIP6, ABCC3 and CPS1 Expression in Resistance of Ovarian Cancer to Taxanes. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/ijms23010073","DOI":"10.3390\/ijms23010073"},{"key":"9862_CR29","doi-asserted-by":"publisher","unstructured":"Balaji SA, Udupa N, Chamallamudi MR, Gupta V, Rangarajan A (2016) Role of the Drug Transporter ABCC3 in Breast Cancer Chemoresistance. PLoS One 11: e0155013. https:\/\/doi.org\/10.1371\/journal.pone.0155013","DOI":"10.1371\/journal.pone.0155013"},{"key":"9862_CR30","doi-asserted-by":"publisher","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A et al (2015) Proteomics. Tissue-based map of the human proteome. Science 347: 1260419. https:\/\/doi.org\/10.1126\/science.1260419","DOI":"10.1126\/science.1260419"},{"key":"9862_CR31","doi-asserted-by":"publisher","unstructured":"Pang Y, Gong S, Tetti M, Sun Z, Mir-Bashiri S, Bidlingmaier M et al (2025) EGR1 regulates oxidative stress and aldosterone production in adrenal cells and aldosterone-producing adenomas. Redox Biol 80: 103498. https:\/\/doi.org\/10.1016\/j.redox.2025.103498","DOI":"10.1016\/j.redox.2025.103498"},{"key":"9862_CR32","doi-asserted-by":"publisher","unstructured":"Yang Y, Tetti M, Vohra T, Adolf C, Seissler J, Hristov M et al (2021) BEX1 Is Differentially Expressed in Aldosterone-Producing Adenomas and Protects Human Adrenocortical Cells From Ferroptosis. Hypertension 77: 1647\u20131658. https:\/\/doi.org\/10.1161\/hypertensionaha.120.16774","DOI":"10.1161\/hypertensionaha.120.16774"},{"key":"9862_CR33","doi-asserted-by":"publisher","unstructured":"Gomez-Sanchez CE, Qi X, Velarde-Miranda C, Plonczynski MW, Parker CR, Rainey W et al (2014) Development of monoclonal antibodies against human CYP11B1 and CYP11B2. Mol Cell Endocrinol 383: 111\u2013117. https:\/\/doi.org\/10.1016\/j.mce.2013.11.022","DOI":"10.1016\/j.mce.2013.11.022"},{"key":"9862_CR34","doi-asserted-by":"publisher","unstructured":"Fernandes-Rosa FL, Amar L, Tissier F, Bertherat J, Meatchi T, Zennaro MC et al (2015) Functional histopathological markers of aldosterone producing adenoma and somatic KCNJ5 mutations. Mol Cell Endocrinol 408: 220\u2013226. https:\/\/doi.org\/10.1016\/j.mce.2015.01.020","DOI":"10.1016\/j.mce.2015.01.020"},{"key":"9862_CR35","doi-asserted-by":"publisher","unstructured":"Sun Z, Kemter E, Pang Y, Bidlingmaier M, Wolf E, Reincke M et al (2025) ATP2A3 in Primary Aldosteronism: Machine Learning-Based Discovery and Functional Validation. Hypertension 82: 319\u2013332. https:\/\/doi.org\/10.1161\/hypertensionaha.124.23817","DOI":"10.1161\/hypertensionaha.124.23817"},{"key":"9862_CR36","doi-asserted-by":"publisher","unstructured":"Juhlin CC, Bertherat J, Giordano TJ, Hammer GD, Sasano H, Mete O (2021) What Did We Learn from the Molecular Biology of Adrenal Cortical Neoplasia? From Histopathology to Translational Genomics. Endocr Pathol 32: 102\u2013133. https:\/\/doi.org\/10.1007\/s12022-021-09667-0","DOI":"10.1007\/s12022-021-09667-0"},{"key":"9862_CR37","doi-asserted-by":"publisher","unstructured":"Nanba K, Vaidya A, Williams GH, Zheng I, Else T, Rainey WE (2017) Age-Related Autonomous Aldosteronism. Circulation 136: 347\u2013355. https:\/\/doi.org\/10.1161\/circulationaha.117.028201","DOI":"10.1161\/circulationaha.117.028201"},{"key":"9862_CR38","doi-asserted-by":"publisher","unstructured":"Lim JS, Rainey WE (2020) The Potential Role of Aldosterone-Producing Cell Clusters in Adrenal Disease. Horm Metab Res 52: 427\u2013434. https:\/\/doi.org\/10.1055\/a-1128-0421","DOI":"10.1055\/a-1128-0421"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-025-09862-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-025-09862-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-025-09862-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:25:36Z","timestamp":1767860736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-025-09862-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9862"],"URL":"https:\/\/doi.org\/10.1007\/s12022-025-09862-3","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"28 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with local ethics committee guidelines and approved by the institutional review board (project number 379\u201310 and 24\u20130696).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17"}}